EAU 2020: The Future of Personalized Treatment: Test the Tumor for a Response

(UroToday.com) Dr. Michael Shen began his discussion on the use of organoid models for studying tumor evolution and drug response. The reasons he uses organoid models include: A need for model systems that can capture tumor heterogeneity Clonal evolution of tumors plays a key role in drug resistance Drug […]

View Original Source at EAU 2020: The Future of Personalized Treatment: Test the Tumor for a Response